San Diego, Nov. 18, 2011 (Shareholders Foundation) -- An investigation on behalf of investors in shares of Chemed Corporation (NYSE: CHE) over possible Violations of Federal Securities Laws was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Chemed Corporation (NYSE CHE) concerning whether the company, certain of its officers and directors, or others have possibly violated federal securities laws. Specifically, the investigation concerns whether certain statements regarding Chemeds business, its prospects and its operations were potentially materially false and misleading at the time they were made.

Chemed Corporation reported that its annual Revenue rose from $1.1billion in 2007 to $1.28billion in 2010 and its Net Income increased from $61.64million for 07 to $81.83million in 2010.

Shares of Chemed Corporation (Public, NYSE:CHE) rose from as low as $35.30 in March 09 to over $71 per share in may 2011.

Then on November 16, 2011, a media outlet reported that Vitas Healthcare Corp., a unit of Chemed Corp., has been accused by a whistleblower in lawsuit of a medicare HMO conspiracy. Additionally, the Department of Justice (DOJ) reportedly is seeking internal Vitas Healthcare Corp documents in an investigation focused on alleged abuses of Federal health-insurance programs. According to the article the government has told the court it suspects Vitas of an extensive scheme to defraud Medicare and Medicaid of hundreds of millions of dollars by falsifying records and hospice certifications.
Following the report shares of Chemed Corporation (Public, NYSE:CHE) fell from $57.52 on Nov. 15, 2011 to as low as $48.43 on November 16, 2011 and closed on Friday, Nov. 18 at $49.77.